The long-term objectives of this application are to understand the biological function of collagen VI and to investigate whether collagen VI is involved in connective tissue disorders. Collagen VI is an abundant microfibrillar component present in almost all tissues. It is composed of three different chains, [alpha1(VI)alpha2(VI)alpha3(VI)], encoded by three genes located on human chromosome 21 and 2. During the past eight years, the applicants have elucidated the protein and gene structures for the three chains of human collagen VI. They also have initiated studies concerning the assembly of collagen VI chains and the regulation of collagen VI gene expression. It is becoming increasingly clear that the alpha3(VI) gene plays a key role in controlling the expression of collagen VI. In this renewal application, they propose to continue studying the structure/function, assembly, and regulation of collagen VI with a major emphasis placed on the alpha3(VI) chain. They also propose to use transgenic mice approaches to investigate the biological role of collagen VI in vivo and the phenotypic consequences of mutations in collagen VI genes.
The Specific Aims of this application are: 1) to investigate the structure/function and assembly of collagen VI in vitro using recombinant collagen chains and domains produced in an eukaryotic expression system; 2) to complete the characterization of collagen VI genes by developing microsatellite markers for the human alpha1(VI), alpha2(VI) and alpha3(VI) collagen genes and identifying cis- and trans- regulatory elements controlling the transcription and regulation of the human alpha3(VI) gene; 3) to investigate the expression patterns of the three collagen VI chains and the alternative spliced variants in the mouse; and 4) to study the biological role of collagen VI in vivo and the phenotypic consequences of mutations in the collagen VI gene by preparing and analyzing transgenic mice with inactivated or mutated alpha3(VI) collagen gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR038912-11
Application #
2442805
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1987-07-15
Project End
2000-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Pepe, Guglielmina; Lucarini, Laura; Zhang, Rui-Zhu et al. (2006) COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. Ann Neurol 59:190-5
Lucarini, Laura; Giusti, Betti; Zhang, Rui-Zhu et al. (2005) A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. Hum Genet 117:460-6
Lucioli, S; Giusti, B; Mercuri, E et al. (2005) Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology 64:1931-7
Lampe, A K; Dunn, D M; von Niederhausern, A C et al. (2005) Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet 42:108-20
Pan, Te-Cheng; Zhang, Rui-Zhu; Sudano, Dominick G et al. (2003) New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 73:355-69
Zhang, Rui-Zhu; Sabatelli, Patrizia; Pan, Te-Cheng et al. (2002) Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy. J Biol Chem 277:43557-64
Pepe, Guglielmina; de Visser, Marianne; Bertini, Enrico et al. (2002) Bethlem myopathy (BETHLEM) 86th ENMC international workshop, 10-11 November 2000, Naarden, The Netherlands. Neuromuscul Disord 12:296-305
Dziadek, Marie; Kazenwadel, Janette S; Hendrey, Jaqueline A et al. (2002) Alternative splicing of transcripts for the alpha 3 chain of mouse collagen VI: identification of an abundant isoform lacking domains N7-N10 in mouse and human. Matrix Biol 21:227-41
Verrecchia, F; Chu, M L; Mauviel, A (2001) Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276:17058-62
Camacho Vanegas, O; Bertini, E; Zhang, R Z et al. (2001) Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A 98:7516-21

Showing the most recent 10 out of 53 publications